What They List
- Psilocybin Research
- Psilostudy
- Group Retreat Study
- Clinician Burnout Study
Research
UW Center for Novel Therapeutics in Addiction Psychiatry (NTAP)
Clinical Trial in Seattle, Washington
The UW Center for Novel Therapeutics in Addiction Psychiatry is a University of Washington research program in the Department of Psychiatry and Behavioral Sciences directed by Dr. Nathan Sackett. Source notes describe PsiloStudy, a state-funded trial enrolling about 40 military veterans and first responders with co-occurring PTSD and alcohol use disorder for a single 25 mg psilocybin dose with psychological support and integration therapy. The center is also connected to group psilocybin-assisted therapy retreat research and Dr. Anthony Back's clinician-burnout psilocybin trial.
IntegrationResearchVeteran Friendly
Directory Facts
- Status
- Active Research Center
- Price
- Not published
- Hours
- Verify with provider
- License / Record
- Not listed
- Last Verified
- 2026-06-15
Location
University of Washington, Seattle, WA
Source Notes
Washington complete dataset import from supplied 2026-06-15 prompt.
Source: UW Newsroom; UW Psilocybin Retreat; UW Clinician Study; RCW 19.410
MagicMushroomsDirectory does not provide medical, legal, or purchasing advice. Verify current laws, provider status, and eligibility before contacting any listing.